SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Esperion Therapeutics, Inc. and...
January 15 2016 - 4:45PM
The Law Offices of Vincent Wong announce that a class action
lawsuit has been commenced in the USDC for the Eastern District of
Michigan on behalf of investors who purchased Esperion
Therapeutics, Inc. (NASDAQ:ESPR) securities between August 18, 2015
and September 28, 2015.
Click here to learn about the case:
http://docs.wongesq.com/ESPR-Info-Request-Form-1062.
There is no cost or obligation to you.
The complaint alleges that Defendants issued
false and misleading statements regarding the Company’s business
and prospects, including that there was no clear path to approval
for ETC-1002, the Company’s lead product candidate designed to
lower LDL-cholesterol levels, and that the FDA had encouraged the
Company to initiate a cardiovascular outcomes trial (“CVOT”) and
that completion of a CVOT could be necessary prior to approval of
ETC-1002.
On August 17, 2015, Esperion reported to
investors material events from an August 2015 meeting with the FDA;
the Company stated that during the meeting it was informed by the
FDA that the Company would not have to complete a CVOT to gain
approval of ETC-1002. Then in a September 28, 2015 news release the
Company noted that the FDA had actually “encouraged the Company to
initiate a cardiovascular outcomes trial promptly” and it may be
necessary to have a completed CVOT prior to approval.
If you suffered a loss in Esperion
Therapeutics you have until March 14, 2016 to request that
the Court appoint you as lead plaintiff. Your ability to share in
any recovery doesn’t require that you serve as a lead plaintiff. To
obtain additional information, contact Vincent Wong, Esq. either
via email vw@wongesq.com, by telephone at 212.425.1140, or visit
http://docs.wongesq.com/ESPR-Info-Request-Form-1062.
Vincent Wong, Esq. is an experienced attorney
that has represented investors in securities litigations involving
financial fraud and violations of shareholder rights.
Attorney advertising. Prior results do not guarantee similar
outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jul 2023 to Jul 2024